Amal El Beshlawy
Prof. Dr. Pediatric Hematology
(email)
Pages that link to A double-blind, placebo-controlled phase II study of the efficacy and safety of 2,2-dimethylbutyrate (HQK-1001), an oral fetal globin inducer, in sickle cell disease.
View
What links here
No backlinks found.
Bio
Professor Amal El-Beshlawy CV
Publications
Short CV